Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 85 clinical trials
A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer

combination with Letrozole in Previously Untreated Patients with HR-positive, HER2-negative Advanced Breast Cancer

  • 0 views
  • 04 May, 2022
  • 1 location
Exemestane Letrozole or Anastrozole in Treating Postmenopausal Women With Clinical Stage II and III Estrogen Receptor Positive Breast Cancer

are exemestane, anastrozole, letrozole. The purpose of this study is to find out whether it is better to receive exemestane, anastrozole, or letrozole to improve the chance that the

exemestane
estrogen
anastrozole
hormone therapy
estrogen receptor
  • 33 views
  • 07 Nov, 2020
  • 1 location
Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole

, interventional, and randomized study. All patients who are on oral daily letrozole (2.5 mg), will be randomly assigned to receive either immediate or delayed ZOL (4 mg via 15-min infusion every 6 months) for 24

  • 0 views
  • 31 Dec, 2021
  • 1 location
A Study of Lerociclib in Participants With Advanced Breast Cancer

first line endocrine therapy such as tamoxifen, anastrozole, or letrozole (2L population). All premenopausal or perimenopausal female participants, and all male participants, must be receiving goserelin

  • 0 views
  • 15 Jun, 2022
  • 5 locations
Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7) (HERMIONE-7)

The HERMIONE-7 trial is a phase II, single-arm, open-label, multicenter study in HR+, HER2- advanced breast cancer patients who have received HD-FUL as first-line endocrine treatment for their metastatic disease. Patients will receive aromatase inhibitors plus Abemaciclib.

cish
metastasis
aromatase inhibitor
progesterone
abemaciclib
  • 39 views
  • 25 Mar, 2022
  • 38 locations
Letrozole in Stimulated IVF Cycles

. One of the reasons is an adverse effect of high serum estradiol levels following FSH stimulation on the lining of the uterus. Letrozole is a drug used in the prevention of recurrence of breast

androgens
estradiol
ovarian stimulation
follicle stimulating hormone
antral
  • 371 views
  • 19 Apr, 2022
  • 2 locations
A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS

, fixed acupuncture, letrozole or placebo letrozole. Patients will receive treatment for 16 weeks and the primary outcome is live birth.

  • 43 views
  • 23 Apr, 2022
  • 1 location
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) (MATAO)

The purpose of this study is to evaluate the efficacy of addition of letrozole to the standard maintenance therapy in subjects following a primary diagnosis of Estrogen-receptor (ER) positive

peritoneal cancer
letrozole
ovarian epithelial carcinoma
cancer of the ovary
platinum-based chemotherapy
  • 2 views
  • 23 Mar, 2022
  • 15 locations
To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer

: inavolisib as a single agent (Arm A), inavolisib in combination with palbociclib and letrozole (Arm B), inavolisib in combination with letrozole (Arm C), inavolisib in combination with fulvestrant (Arm D

trastuzumab
epidermal growth factor receptor
metastasis
mammogram
letrozole
  • 96 views
  • 18 Jun, 2022
  • 12 locations
Live Birth After Letrozole-stimulated Cycles Versus Hormone Replacement Treatment Cycles for the First Frozen Embryo Transfer in Women With PCOS

freezing. Subjects will be randomized to letrozole-stimulated group or hormone replacement treatment group in their first frozen embryo transfer cycle, and their pregnancy and perinatal outcomes during

  • 0 views
  • 02 May, 2022
  • 1 location